Cancer-associated retinopathy: A new mechanistic insight on vascular remodeling

Cell Cycle

Volumn 9, Issue 10, 2010, Pages 1882-1885

  Cao, Renhai ^a   Cao, Yihai ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; PlGF; Retinopathy; Vascular remodling; VEGF

Indexed keywords

ANGIOGENIC FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

CACHEXIA; CELL LOSS; ENDOTHELIUM CELL; FIBROSARCOMA; IMMUNITY; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; NEOPLASM; NERVE CELL; NONHUMAN; PARANEOPLASTIC SYNDROME; PERICYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA; RETINA BLOOD VESSEL; RETINOPATHY; REVIEW; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

EID: 77953630780     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.10.11521     Document Type: Review

References (25)

1. Kornguth SE. Neuronal proteins and paraneoplastic syndromes. N Engl J Med 1989; 321:1-4.
2. Lewis HA, Musunuru K, Jensen KB, Edo C, Chen H, Darnell RB, Burley SK. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell 2000; 100:323-32. (Pubitemid 30353088)
3. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987; 50:555-63.
4. Xue Y, Religa P, Cao R, Hansen AJ, Lucchini F, Jones B, et al. Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome. Proc Natl Acad Sci USA 2008; 105:18513-8.
5. Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve and cancer cells. N Engl J Med 1989; 321:1589-94. (Pubitemid 20008239)
6. Matus G, Dicato M, Focan C. Cancer associated retinopathy (CAR). Two clinical cases and review of the literature. Rev Med Liege 2007; 62:166-9.
7. Sobottka B, Schlote T, Besch D, Djelebova T, Wilhelm H, Zrenner E. Carcinoma-associated retinopathy: a review with clinical examples. Klin Monbl Augenheilkd 2000; 216:17-24.
8. Ohguro H, Takaya T, Ogawa K, Suzuki J, Nakagawa T. Cancer-associated retinopathy. Nippon Ganka Gakkai Zasshi 1997; 101:283-7.
9. Ebos JM, Lee CR, Christensen JG, Mutsaers AJ, Kerbel RS. Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy. Proc Natl Acad Sci USA 2007; 104:17069-74.
10. Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2009; 2:1.
11. Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression and high affinity binding to Flk-1/KDR. J Biol Chem 1996; 271:3154-62.
12. Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002; 1:99-108.
13. Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007; 131:463-75.
14. Cao R, Xue Y, Hedlund EM, Zhong Z, Tritsaris K, Tondelli B, et al. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proc Natl Acad Sci USA 2010; 107:856-61.
15. Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest 2007; 117:2766-77.
16. Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM, et al. FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci USA 2008; 105:10167-72.
17. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, Wahlberg E. Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J 2009; 23:153-63.
18. Eriksson A, Cao R, Roy J, Tritsaris K, Wahlestedt C, Dissing S, et al. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability. Circulation 2003; 107:1532-8.
19. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-3. (Pubitemid 30208166)
20. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008; 12:1193-201.
21. Baracos VE. Cancer-associated cachexia and underlying biological mechanisms. Annu Rev Nutr 2006; 26:435-61.
22. Couch M, Lai V, Cannon T, Guttridge D, Zanation A, George J, et al. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment. Head Neck 2007; 29:401-11.
23. Murphy RA, Wilke MS, Perrine M, Pawlowicz M, Mourtzakis M, Lieffers JR, et al. Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients. Clin Nutr 2009.
24. Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Banas T. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNFalpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients. Clin Biochem 2007; 40:1353-60. (Pubitemid 350151421)
25. Ravasco P, Monteiro-Grillo I, Camilo M. How relevant are cytokines in colorectal cancer wasting? Cancer J 2007; 13:392-8.